The Industry Standard: Intelligence for the Information Economy

  September 5, 2001
  NEWS & ANALYSIS
   Headlines
   Money & Markets
   Tech & Telecom
   Media & Marketing
   Metrics & Stats
   Policy & Politics
  SEARCH
   
  advanced search
  SERVICES
   Company Index
   Newsletters
   Wireless
  PRINT EDITION
   Read the Magazine

Home > Company Index > Drugs > Biotechnology-Research > InterMune, Inc.

InterMune, Inc.
Nasdaq: ITMN
Change
symbol:
     
 PROFILE
Orphan drugs for sick children? InterMune hopes so. The company licenses ACTIMMUNE (interferon gamma-1b) from Connetics, its former parent, for diseases that primarily affect children. It currently markets ACTIMMMUNE for chronic granulomatous disease, an immune system disease, and osteopetrosis, a disease causing abnormal bone growth. The company is testing the drug as a treatment for idiopathic pulmonary fibrosis and drug-resistant tuberculosis. The firm also markets Amphotec, a treatment for the life-threatening fungal infection invasive aspergillosis; InterMune licenses this product from ALZA. InterMune seeks to expand the use of its products and to gain marketing approval in other countries.

 COMPETITION
Biogen, Inc. (BGEN)
SciClone Pharmaceuticals, Inc. (SCLN)
Viragen, Inc. (VRA)

 STOCK ANALYSIS
 View by:
 Day 
 Day 
 Month 
 Month 
 Year 
 Year 
FURTHER ANALYSIS
• Advanced Charting
• Deals

 FINANCIAL OVERVIEW
Fiscal Year-End: December
2000 Sales (mil.): 11.20
1-Yr. Sales Growth: 1,766.7%
Employees: 91
Revenue per employee: $123,076.92

 KEY PEOPLE
• W. Scott Harkonen
    CEO
• Timothy P. Lynch
    CFO

 CONTACT INFO
1710 Gilbreth Rd., Ste. 301
Burlingame, CA 94010
US
Phone: 650-409-2020
Fax: 650-259-0774
Online: Web Site

Company Data   News, quotes & more       

Hoovers Online   Hoover's Company Capsule
Copyright © 2001, Hoover's Inc. Austin, Texas.
For changes and updates, contact Hoover's directly.


ADVERTISEMENT
FEATURED LINKS
Home |  Customer Service |  About Us
Australia |  Brazil |  China |  Korea |  Norway |  Poland |  Sweden |  Taiwan

Copyright ©2001 Standard Media International. Privacy Policy
Stock data provided by Stockpoint and its data suppliers. Copyright © 1995-2001